You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2025

Patent: 10,100,034


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,100,034
Title:Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)meth- yl)cyclopropanamine, its crystalline form and its salts
Abstract: The present invention relates a new process to synthesize 1-((4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)meth- yl)cyclopropanamine (AL3818). A stable crystalline form of A13818 has been prepared. Salts and their crystalline forms of AL3818 have been also prepared. Anti-cancer and optometric activities of AL3818 and its salts have been further tested. New process has been outlined in Scheme I. ##STR00001##
Inventor(s): Chen; Guoqing Paul (Westlake, CA), Yan; Changren (Camarillo, CA)
Assignee: Advenchen Pharmaceuticals, LLC (Moorpark, CA)
Application Number:15/659,510
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 10,100,034

Introduction

When analyzing a patent, particularly one like United States Patent 10,100,034, it is crucial to delve into the claims, the underlying technology, and the broader patent landscape. This analysis helps in understanding the patent's novelty, non-obviousness, and the potential impact on the industry.

Understanding the Patent Claims

To begin with, it is essential to dissect the claims of the patent. Claims are the heart of any patent, as they define the scope of the invention and what is protected.

Independent and Dependent Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are critical in determining the scope of the patent.
  • Dependent Claims: These claims refer back to and further limit the independent claims. They often add specific details or narrow down the invention.

The Underlying Technology

Understanding the technology behind the patent is vital for a comprehensive analysis.

Whole Genome and Transcriptome Amplification

Patents like US7718403B2 and US8206913B1, which deal with whole genome and transcriptome amplification, provide context for advanced genetic analysis techniques. These patents describe methods for amplifying DNA or cDNA to obtain a non-biased representation of the original genomic or transcribed sequences, often using primers that avoid forming primer dimers[5][1].

Patent Landscape

The patent landscape includes existing patents, published patent applications, and other relevant intellectual property.

Prior Art and Anticipation

A key aspect of patent analysis is determining whether the invention is novel and non-obvious over prior art. According to 35 U.S.C. 102, a claimed invention can be rejected if it is anticipated by prior art, meaning every element of the claim must be found in a single prior art reference[3].

Global Patent System

The global patent system, facilitated by tools like the Global Dossier and Common Citation Document (CCD), helps in identifying related applications and prior art across different jurisdictions. This is crucial for understanding the international scope and potential conflicts of the patent[4].

Critical Analysis of Claims

Novelty and Non-Obviousness

  • Novelty: The claims must be new and not anticipated by prior art. This involves a thorough search of existing patents and publications to ensure no identical invention has been disclosed before.
  • Non-Obviousness: The invention must be significantly different from existing technology and not obvious to a person of ordinary skill in the field. This often involves demonstrating unexpected results or solving a long-standing problem in a novel way.

Enablement and Written Description

The patent must provide sufficient detail to enable a person of ordinary skill in the field to make and use the invention. The written description requirement ensures that the inventor has clearly described the invention and its various embodiments[3].

Industry Impact and Market Domination

Competitive Advantage

A strong patent can provide a significant competitive advantage by preventing others from making, using, or selling the invention. This can be particularly powerful in fields like genomics and molecular biology, where intellectual property is a key driver of innovation.

Licensing and Collaboration

Patents can also facilitate licensing agreements and collaborations. Companies may license their patented technologies to other firms, generating revenue and expanding the technology's reach.

Examples and Case Studies

Real-World Applications

For instance, patents related to whole genome amplification have been crucial in advancing genetic research and diagnostics. These techniques allow for the analysis of small or degraded DNA samples, which is vital in forensic science, personalized medicine, and basic research[5].

Expert Insights

Industry experts often highlight the importance of robust patent protection in driving innovation. For example, Dr. Francis Collins, former Director of the National Institutes of Health, has emphasized the role of intellectual property in translating scientific discoveries into practical applications.

Statistics and Trends

Patent Filings

The number of patent filings in the biotechnology and genomics sectors has been increasing, reflecting the growing importance of intellectual property in these fields. According to the USPTO, the number of biotechnology patent applications has seen a steady rise over the past decade[4].

Litigation and Enforcement

Patent litigation is a significant aspect of the patent landscape. Companies often engage in legal battles to protect their intellectual property rights. For example, the biotech industry has seen several high-profile patent disputes in recent years.

Key Takeaways

  • Comprehensive Search: Conduct a thorough search of prior art to ensure the novelty and non-obviousness of the invention.
  • Clear Claims: Ensure that the patent claims are clear, specific, and well-supported by the written description.
  • Industry Impact: Understand the potential impact of the patent on the industry, including competitive advantages and licensing opportunities.
  • Global Considerations: Consider the global patent landscape and potential international conflicts or opportunities.

FAQs

Q: What is the significance of whole genome and transcriptome amplification in genetic research? A: Whole genome and transcriptome amplification are crucial for analyzing small or degraded DNA samples, which is vital in various fields such as forensic science, personalized medicine, and basic research.

Q: How does the global patent system affect patent filings and enforcement? A: The global patent system, facilitated by tools like the Global Dossier and CCD, helps in identifying related applications and prior art across different jurisdictions, making it easier to manage and enforce patents internationally.

Q: What are the key elements to consider when analyzing patent claims? A: The key elements include novelty, non-obviousness, enablement, and the written description requirement. Ensuring these elements are met is crucial for the validity and enforceability of the patent.

Q: How can a strong patent provide a competitive advantage? A: A strong patent can prevent others from making, using, or selling the invention, thereby providing a significant competitive advantage in the market.

Q: What role does intellectual property play in advancing biotechnology and genomics? A: Intellectual property plays a critical role in driving innovation in biotechnology and genomics by protecting inventions and encouraging investment in research and development.

Sources

  1. US8206913B1 - Amplification and analysis of whole genome and whole transcriptome libraries generated by a DNA polymerization process - Google Patents
  2. Patent 2755821 Summary - Canadian Patents Database
  3. 2131-Anticipation — Application of 35 U.S.C. 102 - USPTO
  4. Search for patents - USPTO
  5. US7718403B2 - Amplification and analysis of whole genome and whole transcriptome - Google Patents

More… ↓

⤷  Try for Free

Details for Patent 10,100,034

ApplicantTradenameBiologic IngredientDosage FormBLAApproval DatePatent No.Expiredate
Genentech, Inc. LUCENTIS ranibizumab Injection 125156 June 30, 2006 ⤷  Try for Free 2035-05-04
Genentech, Inc. LUCENTIS ranibizumab Injection 125156 August 10, 2012 ⤷  Try for Free 2035-05-04
Genentech, Inc. LUCENTIS ranibizumab Injection 125156 October 13, 2016 ⤷  Try for Free 2035-05-04
Genentech, Inc. LUCENTIS ranibizumab Injection 125156 March 20, 2018 ⤷  Try for Free 2035-05-04
>Applicant>Tradename>Biologic Ingredient>Dosage Form>BLA>Approval Date>Patent No.>Expiredate
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.